Safety and Efficacy of PMI-150 (Intranasal Ketamine) for the Treatment of Breakthrough Pain in Cancer Patients
Clinical trial NCT00492388 · TERMINATED
Trial details
- NCT number
- NCT00492388
- Sponsor
- Hospira, now a wholly owned subsidiary of Pfizer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2011-08-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.